Cite
MLA Citation
Sarfaraz Hasni et al.. “183 A phase 1B/2A trial of tofacitinib, an oral janus kinase inhibitor, in systemic lupus erythematosus.” Lupus science & medicine, vol. 6, n.d., pp. A139–A140. http://access.bl.uk/ark:/81055/vdc_100144723174.0x000001